Farmacia
Facultad
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (132)
2024
-
Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis
Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487
2023
-
A comparative NMR-based metabolomics study of lung parenchyma of severe COVID-19 patients
Frontiers in Molecular Biosciences, Vol. 10
-
A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells
Cellular and Molecular Immunology, Vol. 20, Núm. 12, pp. 1499-1512
-
An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)
Frontiers in Microbiology, Vol. 14
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Benchtop NMR-Based Metabolomics: First Steps for Biomedical Application
Metabolites, Vol. 13, Núm. 5
-
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923
-
Comparison of Algorithms to Compute Relaxation Time Maps in Magnetic Resonance Imaging
Applied Sciences (Switzerland), Vol. 13, Núm. 7
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Dietary Supplementation with a Cocoa–Carob Blend Modulates Gut Microbiota and Prevents Intestinal Oxidative Stress and Barrier Dysfunction in Zucker Diabetic Rats
Antioxidants, Vol. 12, Núm. 8
-
Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets
Frontiers in Cardiovascular Medicine
-
Editorial: Rising stars in cancer metabolism 2022
Frontiers in Oncology
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
-
Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging Assessments in a Mouse Model of Implant-Related Bone and Joint Staphylococcus aureus Infection
Microbiology spectrum, Vol. 11, Núm. 3, pp. e0454022
-
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases, Vol. 10, Núm. 2
-
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
Pharmacological Research, Vol. 189
-
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296
-
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435
-
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14